当前位置:首页 - 行情中心 - 沃森生物(300142) - 财务分析

沃森生物

(300142)

  

流通市值:223.64亿  总市值:229.21亿
流通股本:15.68亿   总股本:16.07亿

沃森生物(300142)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润5.11亿元,每股收益0.26元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益1139536.00万元,未分配利润290283.65万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产1558886.93万元,负债419350.93万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入4,113,772,327.173,158,044,365.352,167,671,315.8833,267,364.92
营业总成本3,152,213,298.292,320,868,365.211,526,144,421.03661,539,530.54
营业利润613,966,148.25779,311,646.09632,055,471.94214,478,608.25
利润总额598,976,487.3774,221,056.21628,023,759.87210,731,935.35
净利润511,325,097.99697,229,401.89562,549,133.38198,304,000.23
其他综合收益----
综合收益总额511,325,097.99697,229,401.89562,549,133.38198,304,000.23
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计8,733,170,395.368,790,013,337.188,996,269,388.778,875,468,146.88
非流动资产合计6,855,698,878.046,801,140,608.856,654,064,647.26,559,179,078.3
资产总计15,588,869,273.415,591,153,946.0315,650,334,035.9715,434,647,225.18
流动负债合计3,203,906,735.463,032,084,782.013,263,990,487.553,337,105,308.88
非流动负债合计989,602,515.97957,804,838.15919,759,491.06906,887,509.35
负债合计4,193,509,251.433,989,889,620.164,183,749,978.614,243,992,818.23
归属于母公司股东权益合计9,349,276,209.079,551,615,624.599,453,478,984.069,258,559,867.37
股东权益合计11,395,360,021.9711,601,264,325.8711,466,584,057.3611,190,654,406.95
负债和股东权益合计15,588,869,273.415,591,153,946.0315,650,334,035.9715,434,647,225.18
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计5,084,958,951.523,740,025,436.082,260,200,652.221,034,934,922.93
经营活动现金流出小计3,951,190,153.792,879,089,071.861,874,533,781.8831,734,669.85
经营活动产生的现金流量净额1,133,768,797.73860,936,364.22385,666,870.42203,200,253.08
投资活动现金流入小计147,521,689.62147,181,164.62147,017,506.12198,354.5
投资活动现金流出小计955,515,596.79721,409,282.85464,262,407.4249,529,143.08
投资活动产生的现金流量净额-807,993,907.17-574,228,118.23-317,244,901.28-249,330,788.58
筹资活动现金流入小计632,008,709.23353,468,312.12258,073,814.48118,449,463.92
筹资活动现金流出小计395,364,767.13359,724,625.62258,257,615.65112,408,393.69
筹资活动产生的现金流量净额236,643,942.1-6,256,313.5-183,801.176,041,070.23
汇率变动对现金及现金等价物的影响2,274,863.672,602,714.181,050,183.78-322,694.08
现金及现金等价物净增加额564,693,696.33283,054,646.6769,288,351.75-40,412,159.35
期末现金及现金等价物余额4,354,862,711.584,073,223,661.923,859,457,3673,750,456,855.9
TOP↑